Variable drug metabolism genes in Arab population

被引:41
作者
Bu, R
Gutiérrez, MI
Al-Rasheed, M
Belgaumi, A
Bhatia, K
机构
[1] King Faisal Specialist Hosp & Res Ctr, King Fahad Natl Ctr Childrens Canc & Res, Riyadh 11211, Saudi Arabia
[2] Int Network Canc Treatment & Res, Brussels, Belgium
关键词
CYP1A1; NAT2; GSTs; MTHFR; MTR (MS); NQO*1; genetic polymorphism; risk of cancer; toxicity; population genetic structure;
D O I
10.1038/sj.tpj.6500251
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cataloging interethnic differences in the distribution of genotypes of drug metabolic genes provides valuable information for profiling the pharmacogenetics of a population. We used PCR analysis to catalog the frequencies of alleles and genotypes for CYP1A1, NAT2, GSTs, MTHFR, MTR ( MS) and NQO*1 in Arabs. The frequencies of alleles and/or genotypes for CYP1A1*2A, GSTT1 null, GSTT1 and GSTM1 double null, and GSTP1 A1578G in Arabs were significantly higher than those reported in Caucasians. However, the distribution of NAT2 acetylator phenotypes in both populations was similar. In contrast, the frequencies of MTHFR 677T allele and the combined (677+1298) genotypes for low activity were lower than those reported in Caucasians. Other alleles in Arabs, including CYP1A1 T3801C and GSTP1 A1578G were present in frequencies similar to Africans. The overall profile of variations in metabolism genes in Arabs is thus unique.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 43 条
[1]   Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia [J].
Allan, JM ;
Wild, CP ;
Rollinson, S ;
Willett, EV ;
Moorman, AV ;
Dovey, GJ ;
Roddam, PL ;
Roman, E ;
Cartwright, RA ;
Morgan, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11592-11597
[2]   Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia [J].
Anderer, G ;
Schrappe, M ;
Brechlin, AM ;
Lauten, M ;
Muti, P ;
Welte, K ;
Stanulla, M .
PHARMACOGENETICS, 2000, 10 (08) :715-726
[3]  
Botto LD, 2000, AM J EPIDEMIOL, V151, P862
[4]  
Brockton N, 2000, AM J EPIDEMIOL, V151, P846
[5]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[6]  
Cascorbi I, 1996, CANCER RES, V56, P3961
[7]   Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): Dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A [J].
Celander, M ;
Hahn, ME ;
Stegeman, JJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 329 (01) :113-122
[8]   Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture [J].
Celander, M ;
Weisbrod, R ;
Stegeman, JJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) :749-753
[9]  
Chabner BA, 2002, ONCOLOGIST, V7, P34
[10]   Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate [J].
Chiusolo, P ;
Reddiconto, G ;
Casorelli, I ;
Laurenti, L ;
Sorà, F ;
Mele, L ;
Annino, L ;
Leone, G ;
Sica, S .
ANNALS OF ONCOLOGY, 2002, 13 (12) :1915-1918